Vyant Bio, Inc.

VYNT · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Assets
Cash & Equivalents$10,041$9,394$11,702$16,440
Short-Term Investments$0$0$0$0
Receivables$323$383$484$585
Inventory$53$66$437$497
Other Curr. Assets$1,092$2,283$3,625$2,942
Total Curr. Assets$11,509$12,126$16,248$20,464
Property Plant & Equip (Net)$2,648$2,840$2,792$2,672
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,048$8,073$7,771$9,393
Total NC Assets$3,696$10,913$10,563$12,065
Other Assets$0$0$0$0
Total Assets$15,205$23,039$26,811$32,529
Liabilities
Payables$655$897$1,040$1,765
Short-Term Debt$565$550$454$399
Tax Payable$0$0$0$0
Deferred Revenue$72$72$72$72
Other Curr. Liab.$2,373$5,174$5,941$5,236
Total Curr. Liab.$3,665$6,693$7,507$7,472
LT Debt$1,631$1,778$1,737$1,855
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$728$780$834
Total NC Liab.$1,631$2,506$2,517$2,689
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,296$9,199$10,024$10,161
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$3$3
Retained Earnings-$101,503-$97,244-$93,781-$87,976
AOCI-$32$74-$62-$70
Other Equity$111,443$111,009$110,627$110,411
Total Equity$9,909$13,840$16,787$22,368
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,205$23,039$26,811$32,529
Net Debt-$7,845-$7,066-$9,511-$14,186
Vyant Bio, Inc. (VYNT) Financial Statements & Key Stats | AlphaPilot